Skip to contentN
National Health Investors Inc
N
NHINational Health Investors Inc Q4 2017 · 10-K
Revenue$71.08M$71.08M+9.4% vs Q4 2016 Net Income$37.80M$37.80M−8.2% vs Q4 2016 EPS Diluted$0.90$0.90−12.6% vs Q4 2016 Operating Cash Flowderived$51,365,000+7.2% The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR
Margins · derivedNet margin53.2%−10.2 pt vs Q4 2016
ended Dec 31, 2017 · filed Feb 16, 2018 · 47 d after period end